Target intelligence / Profile preview

Novel transcript, antisense to CARMIL1 (ENSG00000294657)

Target
ENSG00000294657
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA
01

Overview

ENSG00000294657 is a long noncoding RNA annotated as "novel transcript, antisense to CARMIL1," meaning it is transcribed from the opposite strand of the CARMIL1 gene locus. As an antisense lncRNA, it may regulate the expression of the CARMIL1 gene through mechanisms such as transcript interference, chromatin modification, or effects on mRNA stability and translation, as described for other antisense lncRNAs[5]. There is currently no evidence that this lncRNA encodes a protein or acts as a therapeutic target, and its precise biological roles are not yet characterized in the literature. Its function may be inferred from the broader class of antisense lncRNAs, which are known to influence gene expression and are increasingly investigated in cancer and gene regulation contexts[3][5].

02

Mechanism of action

None reported; general mechanism for antisense lncRNAs includes regulation of neighboring gene expression through RNA-RNA interactions or modulation of transcription/translation

03

Biological functions

Regulation of gene expression (cis and potentially trans regulation of neighboring or distant genes)Possible modulation of chromatin status and mRNA translation (functions inferred from the general roles of antisense lncRNAs)
04

Disease associations

Other (lncRNAs, including antisense lncRNAs, have roles in cancer and other diseases, but no published associations for this specific transcript were found)

Beyond the preview

Go deeper on Novel transcript, antisense to CARMIL1 (ENSG00000294657).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CARMIL1 (ENSG00000294657).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call